New approaches to coronary heart disease: Induction of neovascularisation by growth factors

BioDrugs

Volumn 11, Issue 5, 1999, Pages 301-308

  Stegmann, Thomas J ^a  

^a KLINIKUM FULDA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; VASCULOTROPIN;

ANGIOGENESIS; CAPILLARY DENSITY; CLINICAL RESEARCH; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; GENE THERAPY; GENE TRANSFER; HEART MUSCLE; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

EID: 0032905193     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-199911050-00002     Document Type: Review

References (51)

1. Loop FD. Coronary artery surgery: the end of the beginning. Eur J Cardiothorac Surg 1998; 14: 554-71
2. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235: 442-7
3. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267: 10931-4
4. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 1995; 333: 1757-63
5. Burgess WH, Mehrman T, Friesel R, et al. Multiple forms of endothelial cell growth factor. Rapid isolation and biological and chemical characterization. J Biol Chem 1985; 260: 11389-92
6. Thomas KA. Vascular endothelial growth factor, a potent and selective angiogenetic agent. J Biol Chem 1996; 271: 603-6
7. Thompson JA, Haudenschild CC, Anderson KD, et al. Heparin-binding growth factor induces the formation of organoid neovascular structures in vivo. Proc Natl Acad Sci U S A 1989; 86; 7928-32
8. Dvorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor, micro-vascular hyperpermeability and angiogenesis. Am J Pathol 1995; 146: 1029-39
9. Friesel R, Burgess WH, Mehrman T, et al. The characterization of the receptor for endothelial cell growth factor by covalent ligand attachment. J Biol Chem 1986; 261: 7581-4
10. Ware JA, Simons M. Angiogenesis in ischemic heart disease. Nature Med 1997; 3: 158-64
11. Slavin J. Fibroblast growth factors: at the heart of angiogenesis. Cell Biol In 1995; 19: 431-44
12. Kuwabara K, Ogawa S, Matsumoto M, et al. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc Natl Acad Sci U S A 1995; 92: 4606-10
13. Shweiki D, Itin A, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-5
14. Ferrara N, Carrer-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380: 439-42
15. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-6
16. Gimbrone MA Jr, Cotran RS, Folkman J. Endothelial regeneration and turnover: studies with human endothelial cell cultures. Ser Haematol 1973; 6: 453-5
17. Shing Y, Folkman J, Sullivan R, et al. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 1984; 223: 1296-8
18. Muciag T, Mehrman T, Friesel R, et al. Heparin binds endothelial cell growth factor, the principal mitogen in the bovine brain. Science 1984; 225: 932-5
19. Baird A, Bohlen P, Esch F, et al. Acidic fibroblast growth factor (FGF) from bovine brain: amino-terminal sequence and comparison with basic FGF. EMBO J 1985; 4 (8): 1951-6
20. Taylor S, Folkman J. Protamine is an inhibitor of angiogenesis. Nature 1982; 297: 307-12
21. Crum R, Szabo S, Folkman J. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 1985; 230: 1375-8
22. White CW, Sondheimer HM, Crouch EC, et al. Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. N Engl J Med 1989; 320: 1197-200
23. Sorelle R. Two sides of the same coin. Circulation 1998; 98: 383-4
24. 165 in patient with ischemic limb. Lancet 1996; 348: 370-4
25. 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998; 97: 1114-23
26. Schumacher B, Pecher P, von Specht BU, et al. Induction of neoangiogenesis in ischemic myocardium by human growth factors. First clinical results of a new treatment of coronary heart disease. Circulation 1998; 97 (7): 645-50
27. Tuder RM, Flook BE, Voelkel NF. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest 1995; 95: 1798-807
28. Nomura M, Yamagishi S, Havada S, et al. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J Biol Chem 1995; 270: 28316-24
29. Westernacher D, Schaper W. A novel heart derived inhibitor of vascular cell proliferation. Purification and biological activity. J Mol Cell Cardiol 1995; 27: 1535-43
30. Yanagisawa-Miwa A, Uchida Y, Nakamura F, et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992: 257: 1401-3
31. Battler A, Scheinowitz M, Bor A, et al. Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium. J Am Coll Cardiol 1993; 22: 2001-6
32. Giordano FJ, Ping P, McKirnan MD, et al. Intracoronary transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nature Med 1996; 2: 534-9
33. Lazarous DF, Scheinowitz M, Shou M, et al. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 1995; 91: 145-53
34. Unger EF, Banai S, Shou M, et al. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 1944; 266: 1588-95
35. Harada K, Grossman W, Friedman M, et al. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest 1994; 94: 623-30
36. Banai S, Jaklitsch MT, Casscells W, et al. Effects of acidic fibroblast growth factor on normal and ischemic myocardium. Circulation Res 1991; 69: 76-85
37. Fasol R, Schumacher B, Schlaudraff K, et al. Experimental use of a modified fibrin-glue to induce site-directed angiogenesis from the aorta to the heart. J Thorac Cardiovasc Surg 1994; 107 (6): 1432-9
38. Schlaudraff K, Schumacher B, von Specht BU, et al. Growth of 'new' coronary vascular structures hy angiogenetic growth factor. Eur J Cardiothorac Surg 1993; 7 (12): 637-44
39. Sellke FW, Wang SY, Stamler A, et al. Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemia. Surgery 1996; 120: 182-8
40. Pearlman JD, Hibberd MG, Chuang ML, et al. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nature Med 1995; 1: 1085-9
41. Banai S, Jaklitsch MT, Shou M, et al. Angiogenic-induced enhancement of collateral flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 1994; 89: 2183-9
42. Baffour R, Berman J, Garb JL, et al. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 1992; 16: 181-91
43. Mack CA, Magovern CJ, Budenbender KT, et al. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. J Vasc Surg 1998; 27: 699-709
44. Takeshita S. Zheng LP, Brogi E, et al. Therapeutic angiogenesis. Single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 1994; 93: 662-70
45. Pelletier MP, Giaid A, Sivaraman S, et al. Angiogenesis and growth factor expression in a model of transmyocardial revascularization. Ann Thorac Surg 1998; 66: 12-8
46. Sellke FW,Laham RJ, Edelman R, et al. Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results. Ann Thorac Surg 1998; 65: 1540-4
47. Kuzuya M, Satake S, Esaki T, et al. Induction of angiogenesis by smooth muscle cell-derived factor: possible role in neovascularization in atherosclerotic plaque. J Cell Physiol 1995; 164: 658-67
48. Folkman J. Therapeutic angiogenesis in ischemic limbs [editorial]. Circulation 1998; 97: 1108-10
49. Folkman J. Angiogenic therapy of the human heart [editorial]. Circulation 1998; 97 (7): 628-9
50. Schumacher B, von Specht BU, Haberstroh J, et al. The stimulation of neo-angiogenesis in the ischemic heart by the human growth factor FGF. J Cardiovasc Surg 1998; 39: 445-53
51. Schumacher B, Stegmann T, Pecher P. The stimulution of neoangiogenesis in the ischemic human heart by the growth factor FGF: first clinical results. J Cardiovasc Surg 1998; 39 (6): 783-9